Anthony Muslin

Chief Development Officer @Tectonic Therapeutic, Inc

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2020 — Present

Chief Development Officer @Tectonic Therapeutic, Inc

View department →

Boston, MA, US

EDUCATION

1976 — 1980

Yale University

B.A., History

1980 — 1984

Harvard Medical School

M.D., Medicine

SKILLS

DiabetesObesityLife SciencesMetabolismLifesciencesCardiovascular DiseaseDrug DiscoveryClinical TrialsAnimal ModelsAtherosclerosisScienceInternal MedicineSignal TransductionResearchClinical ResearchPhysiologyHeart FailureCardiovascular MedicineCardiologyMedicineDrug DevelopmentPharmaceutical IndustryCell Biology

ABOUT ANTHONY MUSLIN

Tony Muslin is currently Chief Development Officer, Tectonic Therapeutic, Inc, in Boston, Massachusetts. He was previously Vice President, Head of the Diabetes and Cardiovascular Therapeutic Area at Sanofi Global R&D. Before that, Tony was the Head of Research in Cardiovascular and Metabolic Diseases (CVM) at the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts. At both companies, Tony was responsible for drug discovery programs to help treat atherosclerosis, heart failure, hyperlipidemia, diabetes and obesity. Prior to working in the pharma industry, Tony was the Oliver M. Langenberg Distinguished Professor of the Science and Practice of Medicine and Director of the Center for Cardiovascular Research at Washington University School of Medicine. His lab was focused on the role of signal transduction cascades in the development of heart failure. He trained at Yale, Harvard and UCSF.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anthony Muslin — Chief Development Officer at Tectonic Therapeutic, Inc in Boston, MA, US | Unifers